French company Carmat announces first implant of its artificial heart in a woman By Reuters
[ad_1]

PARIS (Reuters.com – French artificial heartmaker Carmat has announced that the company had successfully implanted its Aeson artificial hearts in a woman on Tuesday.
The procedure took place at UofL Health and Jewish Hospital, performed by University of Louisville doctors.
Stephane Piat from Carmat, the CEO said “This was a significant event because we were able to complete the enrollment for the first cohort patients of the EFS [early feasibility study] but also because this device helped a woman with heart failure.”
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]